Clinical Trial Termination or Withdrawal in Head and Neck Squamous Cell Carcinoma

20261 citationsJournal Articlegreen Open Access

Authors

Stephen T. Sonis · Brigham and Women's Hospital

Elizabeth Franzmann · University of Miami

Alessandro E. P. Villa · Baptist Hospital of Miami

Abstract

In this study, HNSCC CTs were terminated early or withdrawn for a variety of reasons, most commonly due to strategic decisions or poor recruitment. Careful attention to trial characteristics associated with early failure is needed to overcome new barriers to drug development and adapt trial design to common reasons for failure.

Topics & Keywords

Head and Neck Cancer Studies Statistical Methods in Clinical Trials Meta-analysis and systematic reviews

Publication Details

Published in: JAMA Otolaryngology–Head & Neck Surgery

Volume 152, Issue 3, pp. 242-242

DOI: 10.1001/jamaoto.2025.4766

Field-Weighted Citation Impact: 74.17

Command Palette

Clinical Trial Termination or Withdrawal in Head and Neck Squamous Cell Carcinoma

Authors

Abstract

Topics & Keywords

Publication Details